Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda. (2023)
Attributed to:
Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2023.1113194
PubMed Identifier: 36999017
Publication URI: http://europepmc.org/abstract/MED/36999017
Type: Journal Article/Review
Volume: 14
Parent Publication: Frontiers in immunology
ISSN: 1664-3224